Stryker Shares Outstanding 2010-2024 | SYK
- Stryker shares outstanding for the quarter ending March 31, 2024 were 0.385B, a 0.5% increase year-over-year.
- Stryker 2023 shares outstanding were 0.384B, a 0.39% increase from 2022.
- Stryker 2022 shares outstanding were 0.382B, a 0.03% decline from 2021.
- Stryker 2021 shares outstanding were 0.382B, a 0.53% increase from 2020.
Stryker Annual Shares Outstanding (Millions of Shares) |
|
---|---|
2023 | 384 |
2022 | 382 |
2021 | 382 |
2020 | 380 |
2019 | 380 |
2018 | 380 |
2017 | 380 |
2016 | 379 |
2015 | 381 |
2014 | 383 |
2013 | 382 |
2012 | 383 |
2011 | 390 |
2010 | 400 |
2009 | 399 |
Stryker Quarterly Shares Outstanding (Millions of Shares) |
|
---|---|
2024-03-31 | 385 |
2023-12-31 | 384 |
2023-09-30 | 384 |
2023-06-30 | 384 |
2023-03-31 | 383 |
2022-12-31 | 382 |
2022-09-30 | 382 |
2022-06-30 | 382 |
2022-03-31 | 383 |
2021-12-31 | 382 |
2021-09-30 | 383 |
2021-06-30 | 382 |
2021-03-31 | 382 |
2020-12-31 | 380 |
2020-09-30 | 380 |
2020-06-30 | 376 |
2020-03-31 | 380 |
2019-12-31 | 380 |
2019-09-30 | 380 |
2019-06-30 | 380 |
2019-03-31 | 379 |
2018-12-31 | 380 |
2018-09-30 | 380 |
2018-06-30 | 380 |
2018-03-31 | 381 |
2017-12-31 | 380 |
2017-09-30 | 380 |
2017-06-30 | 380 |
2017-03-31 | 379 |
2016-12-31 | 379 |
2016-09-30 | 379 |
2016-06-30 | 379 |
2016-03-31 | 377 |
2015-12-31 | 381 |
2015-09-30 | 381 |
2015-06-30 | 381 |
2015-03-31 | 384 |
2014-12-31 | 383 |
2014-09-30 | 383 |
2014-06-30 | 383 |
2014-03-31 | 383 |
2013-12-31 | 382 |
2013-09-30 | 382 |
2013-06-30 | 381 |
2013-03-31 | 383 |
2012-12-31 | 383 |
2012-09-30 | 383 |
2012-06-30 | 383 |
2012-03-31 | 384 |
2011-12-31 | 390 |
2011-09-30 | 388 |
2011-06-30 | 392 |
2011-03-31 | 394 |
2010-12-31 | 400 |
2010-09-30 | 398 |
2010-06-30 | 399 |
2010-03-31 | 400 |
2009-12-31 | 399 |
2009-09-30 | 400 |
2009-06-30 | 399 |
2009-03-31 | 399 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $125.611B | $20.498B |
Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $179.548B | 23.51 |
Medtronic (MDT) | Ireland | $112.214B | 15.89 |
Boston Scientific (BSX) | United States | $110.560B | 35.22 |
EssilorLuxottica (ESLOY) | France | $102.987B | 0.00 |
Lonza Group Ag (LZAGY) | Switzerland | $43.408B | 0.00 |
Haleon (HLN) | United Kingdom | $38.858B | 28.37 |
ResMed (RMD) | United States | $32.134B | 30.17 |
Terumo (TRUMY) | Japan | $26.594B | 37.56 |
Koninklijke Philips (PHG) | Netherlands | $25.426B | 19.70 |
Zimmer Biomet Holdings (ZBH) | United States | $24.492B | 15.64 |
Baxter (BAX) | United States | $17.846B | 12.69 |
Insulet (PODD) | United States | $12.897B | 57.19 |
Smith & Nephew SNATS (SNN) | United Kingdom | $11.375B | 0.00 |
Demant (WILYY) | Denmark | $11.282B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $8.326B | 27.23 |
BellRing Brands (BRBR) | United States | $7.474B | 35.15 |
Lantheus Holdings (LNTH) | United States | $5.744B | 14.31 |
Haemonetics (HAE) | United States | $4.838B | 23.94 |
GN Store Nord (GNNDY) | Denmark | $4.400B | 24.71 |
Perrigo (PRGO) | Ireland | $4.027B | 12.21 |
Prestige Consumer Healthcare (PBH) | United States | $3.230B | 15.37 |
Envista Holdings (NVST) | United States | $3.140B | 12.96 |
Neogen (NEOG) | United States | $2.961B | 28.48 |
Maravai LifeSciences Holdings (MRVI) | United States | $2.851B | 0.00 |
QuidelOrtho (QDEL) | United States | $2.839B | 15.76 |
Green Thumb Industries (GTBIF) | United States | $2.604B | 51.58 |
TG Therapeutics (TGTX) | United States | $2.547B | 71.65 |
ICU Medical (ICUI) | United States | $2.516B | 22.20 |
Agios Pharmaceuticals (AGIO) | United States | $1.884B | 0.00 |
LeMaitre Vascular (LMAT) | United States | $1.782B | 52.23 |
Verano Holdings (VRNOF) | United States | $1.676B | 0.00 |
Warby Parker (WRBY) | United States | $1.654B | 0.00 |
InMode (INMD) | Israel | $1.596B | 8.48 |
Owens & Minor (OMI) | United States | $1.377B | 12.00 |
AdaptHealth (AHCO) | United States | $1.317B | 9.79 |
National Vision Holdings (EYE) | United States | $1.221B | 38.85 |
AtriCure (ATRC) | United States | $1.062B | 0.00 |
BioLife Solutions (BLFS) | United States | $1.005B | 0.00 |
Canopy Growth (CGC) | Canada | $0.853B | 0.00 |
Evolus (EOLS) | United States | $0.840B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.738B | 15.72 |
Cresco Labs (CRLBF) | United States | $0.736B | 0.00 |
Quanterix (QTRX) | United States | $0.659B | 0.00 |
Valneva SE (VALN) | France | $0.616B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.614B | 14.43 |
PetIQ (PETQ) | United States | $0.593B | 19.38 |
Surmodics (SRDX) | United States | $0.500B | 31.30 |
Jin Medical (ZJYL) | China | $0.474B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.472B | 0.00 |
ZimVie (ZIMV) | United States | $0.465B | 39.60 |
Aurora Cannabis (ACB) | Canada | $0.404B | 0.00 |
OraSure Technologies (OSUR) | United States | $0.365B | 11.74 |
Cerus (CERS) | United States | $0.361B | 0.00 |
Biote (BTMD) | United States | $0.350B | 8.06 |
Zynex (ZYXI) | United States | $0.336B | 45.91 |
Sanara MedTech (SMTI) | United States | $0.281B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.276B | 27.31 |
TriSalus Life Sciences (TLSI) | United States | $0.272B | 0.00 |
MacroGenics (MGNX) | United States | $0.267B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.243B | 15.31 |
Veru (VERU) | United States | $0.208B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.206B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.201B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.200B | 0.00 |
Omeros (OMER) | United States | $0.191B | 0.00 |
High Tide (HITI) | Canada | $0.173B | 0.00 |
Eagleford Energy (GRUSF) | United States | $0.169B | 81.00 |
InterCure (INCR) | Israel | $0.154B | 26.00 |
Quipt Home Medical (QIPT) | United States | $0.138B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.132B | 0.00 |
FitLife Brands (FTLF) | United States | $0.128B | 18.14 |
Cellectar Biosciences (CLRB) | United States | $0.113B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.096B | 0.00 |
MariMed (MRMD) | United States | $0.094B | 0.00 |
Brainsway (BWAY) | Israel | $0.091B | 0.00 |
Fonar (FONR) | United States | $0.091B | 7.82 |
Chimerix (CMRX) | United States | $0.088B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.081B | 0.00 |
Safety Shot (SHOT) | United States | $0.071B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.069B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.060B | 3.91 |
Apyx Medical (APYX) | United States | $0.055B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.055B | 0.00 |
Cytosorbents (CTSO) | United States | $0.053B | 0.00 |
Bright Green (BGXX) | United States | $0.043B | 0.00 |
United-Guardian (UG) | United States | $0.042B | 15.20 |
Modular Medical (MODD) | United States | $0.037B | 0.00 |
ImmuCell (ICCC) | United States | $0.037B | 0.00 |
Exagen (XGN) | United States | $0.032B | 0.00 |
Nephros (NEPH) | United States | $0.024B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.019B | 0.00 |
Agape ATP (ATPC) | $0.019B | 0.00 | |
Flora Growth (FLGC) | United States | $0.016B | 0.00 |
FSD PHARMA (HUGE) | Canada | $0.014B | 0.00 |
GlucoTrack (GCTK) | United States | $0.013B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.010B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.009B | 0.00 |
NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.004B | 0.00 |
Sharps Technology (STSS) | United States | $0.004B | 0.00 |
Senestech (SNES) | United States | $0.004B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.002B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
Smart For Life (SMFL) | United States | $0.000B | 0.00 |
Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
SNDL (SNDL) | Canada | $0.000B | 0.00 |